Home > Insider Trading > Filing (0001181431-12-019610)

Filing Details

Accession Number:: 0001181431-12-019610
Form Type:: 4
Zero Holdings:: No
Publication Time:: 2012-03-27 09:06:15
Reporting Period:: 2012-03-23

Filing Date:: 2012-03-27
Accepted Time:: 2012-03-27 09:06:15
SEC Url:: Form 4 Filing

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1174940	Oragenics Inc	ORNI	Pharmaceutical Preparations (2834)	593410522

Insiders

Cik	Name	Reported Address	Director	Officer	Large Shareholder	Other
1234877	Beverly Koski	1500 West University Parkway Sarasota FL 34243	No	No	Yes	No
1234878	L Christine Koski	1500 West University Parkway Sarasota FL 34243	Yes	No	Yes	No
1234879	Koski Family Lp	1500 West University Parkway Sarasota FL 34243	No	No	Yes	No
1234880	C Robert Koski	1500 West University Parkway Sarasota FL 34243	Yes	No	Yes	No
1234881	L Thomas Koski	1500 West University Parkway Sarasota FL 34243	No	No	Yes	No

Reported Non-Derivative Transactions

Show Other Fields >>

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock	Acquisiton	2012-03-23	6,285,619	$0.00	8,075,619	No	4	P	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	P	Direct

Reported Derivative Transactions

Show Other Fields >>

Sec. Name	Sec. Type	Acquisiton - Disposition	Date	Amount	Price	Amount - 2	Price - 2
Common Stock	Common Stock Warrants (Right to Buy)	Acquisiton	2012-03-23	1,571,405	$0.00	1,571,405	$2.00
Common Stock	Common Stock Warrants (Right to Buy)	Acquisiton	2012-03-23	599,520	$0.00	599,520	$2.00

Remaning Holdings	Exercise Date	Expiration Date	Equity Swap Involved	Transaction Form Type	Transaction Code	Nature of Ownership
1,571,405	2012-03-23	2015-03-22	No	4	P	Direct
599,520	2012-03-23	2015-03-22	No	4	P	Direct

Reported Non-Derivative Holdings

Sec. Name	Remaning Holdings	Nature of Ownership	Explanation
Common Stock	11,400	Direct
Common Stock	451,066	Direct
Common Stock	469,666	Direct
Common Stock	497,666	Indirect	By Trusts
Common Stock	10,000	Indirect	By Koski Management, Inc.

Footnotes

On March 23, 2012, Oragenics, Inc. (the "Company") entered into an Exchange of Notes for Equity Agreement (the "Debt Exchange Agreement") with the Koski Family Limited Partnership ("KFLP"). Pursuant to the terms of the Debt Exchange Agreement, the Company issued 6,285,619 shares of common stock and warrants to acquire 1,571,405 shares of common stock to the KFLP in exchange for the cancellation of an aggregate of $8,737,011 of indebtedness owed to the KFLP under the Company's existing unsecured revolving credit facility. The warrants are exercisable immediately at a price per share of $2.00 and expire three (3) years from the date of issuance.
Shares owned directly by Koski Family Limited Partnership. Shares owned indirectly by Beverly Koski (through Koski Management, Inc. solely owned by Beverly Koski), Christine L. Koski, Robert C. Koski and Thomas L. Koski, each of whom is a general partner of the partnership or the controlling person of a corporate general partner of the partnership.
Each reporting person disclaims beneficial ownership of all indirectly owned securities in excess of such reporting person's pecuniary interest therein, and this report shall not be deemed an admission that the reporting person is the beneficial owner for purposes of Section 16 or any other purpose.
Shares owned directly by Robert C. Koski.
Shares owned directly by Christine L. Koski.
Shares owned directly by Thomas L. Koski.
Shares owned by trusts of which Mr. Robert C. Koski is sole trustee. Such trusts are as follows: the Robert Clayton Koski Trust for the benefit of Anthony James Hunter (100,000 shares); the Robert Clayton Koski Trust for the benefit of Hunter Buchanan Koski (100,000 shares); the Robert Clayton Koski Trust for the benefit of Clayton Ward Bennett (100,000 shares); the Robert Clayton Koski Trust for the benefit of Robert Edward Koski (100,000 shares); and the Robert Clayton Koski Trust for the benefit of Elyse Margaux Koski (97,666 shares). Mr. Koski disclaims beneficial ownership of the shares held by the trusts except to the extent of any pecuniary interest.
Shares owned indirectly by Beverly Koski (through Koski Management, Inc).
On March 23, 2012, the Company also entered into a new loan agreement (the "Loan Agreement") with the KFLP. Pursuant to the Loan Agreement the Company also issued warrants to the KFLP to acquire 599,520 shares of the Company common stock. The warrants are exercisable immediately at a price per share of $2.00 and expire three (3) years from the date of issuance.